TNFRSF1B and cancer: The new metrics allow for novel insights into biological node functions, network pathways, controllability and robustness for instance regarding dominating nodes (cancer mutations, complex genetic diseases), system state behaviour over time (e.g. in differentiation, learning) as well as feedback loops (e.g. autocrine amplifiers) or cross-inhibition (e.g. TNFR1 versus TNFR2 networks).